Skip to main content
University of California San Francisco Give to UCSF
 homepage
  • Areas We Support
  • File a Complaint
  • FAQs
  1. Home
  2. Preparing The Initial IND Application Components

Preparing the Initial IND Application Components

Questions? Contact Clinical Trials Regulatory Support

In this article

  • Overview
  • IND Submission Components
  • IND Forms and Instructions
  • FDA Guidance

Overview

The Sponsor-Investigator submits an IND Application to FDA that includes the components listed here.

IND Submission Components

  1. IND Cover Letter
  2. IND Application Template
  3. FDA Form 1571 - IND Application (and FDA Form 1571 Instructions)
  4. FDA Form 1572 - Statement of the IND Investigator) (see sample Box 8 - Protocol Summary Template)
  5. FDA Form 3454 - Certification: Financial Interests and Arrangements of Clinical Investigators
  6. FDA Form 3455 - Investigator Financial Interest Disclosure
  7. FDA Form 3674 - IND Certification of Compliance
  8. IND Protocol Template
  9. If applicable, Letter of Authorization (LOA) for the right of reference to the information contained in an existing IND application.

IND Forms and Instructions

  • IND Forms and Instructions
  • Information for Investigators submitting INDs 

FDA Guidance

The following FDA documents provide an overview of the IND application process:

  • Investigator-Initiated Investigational New Drug (IND) Applications, especially Regulatory and Administrative Components
  • FAQs about the IND Application
  • Content and Format of IND Applications
  • Exploratory INDs (aka Phase 0)

For specific situations:

  • Request for Orphan Drug Determination
  • Biological IND Submissions
Office of Ethics and Compliance homepage

© 2025 The Regents of the University of California

  • Accessibility
  • Privacy Policy
  • Terms of Use
  • A-Z Website List